Srdjan R. Stankovic
Exec. V.P. and CDO, NEUROGEN CORP.
Companies
- Acadia PharmaceuticalsPresident Nov 20, 2018 to Nov 22, 20221
- Acadia PharmaceuticalsEXECUTIVE VICE PRESIDENT Nov 30, 2015 to Oct 24, 20182
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Acadia Pharmaceuticals ACAD61,234 shares3$1.2M at $19.61Nov 21, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 21, 2022Sold 1,847 shares at $15.07 of Acadia Pharmaceuticals3
- Nov 19, 2022Exercised options 6,250 shares of Acadia Pharmaceuticals3
- Oct 15, 2022Sold 1,326 shares at $15.81 of Acadia Pharmaceuticals4
- Oct 15, 2022Exercised options 2,969 shares of Acadia Pharmaceuticals4
- May 2, 2022Sold 2,865 shares at $18.18 of Acadia Pharmaceuticals5
- Apr 29, 2022Exercised options 9,616 shares of Acadia Pharmaceuticals5
- Feb 23, 2022Sold 1,501 shares at $23.80 of Acadia Pharmaceuticals6
- Feb 23, 2022Exercised options 4,919 shares of Acadia Pharmaceuticals6
- Jan 6, 2022Sold 1,937 shares at $23.05 of Acadia Pharmaceuticals7
- Jan 6, 2022Exercised options 5,444 shares of Acadia Pharmaceuticals7
- Nov 22, 2021Sold 2,803 shares at $19.01 of Acadia Pharmaceuticals8
- Nov 19, 2021Exercised options 6,250 shares of Acadia Pharmaceuticals8
- Oct 18, 2021Sold 1,338 shares at $17.41 of Acadia Pharmaceuticals9
- Oct 15, 2021Exercised options 2,969 shares of Acadia Pharmaceuticals9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAcadia Pharmaceuticals, President
- 2
- 3
- 4SEC EDGARForm 4 filed Oct 18, 2022
- 5SEC EDGARForm 4 filed May 3, 2022
- 6SEC EDGARForm 4 filed Feb 25, 2022
- 7SEC EDGARForm 4 filed Jan 10, 2022
- 8SEC EDGARForm 4 filed Nov 23, 2021
- 9SEC EDGARForm 4 filed Oct 19, 2021